KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Depreciation & Amortization (CF) (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $977.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 48.03% to $977.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 billion, a 58.22% decrease, with the full-year FY2025 number at $4.0 billion, down 58.22% from a year prior.
  • Depreciation & Amortization (CF) was $977.0 million for Q4 2025 at Bristol Myers Squibb, down from $1.0 billion in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.7 billion in Q3 2021 to a low of $977.0 million in Q4 2025.
  • A 5-year average of $2.2 billion and a median of $2.5 billion in 2022 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): rose 7.71% in 2021, then tumbled 61.06% in 2025.
  • Bristol Myers Squibb's Depreciation & Amortization (CF) stood at $2.6 billion in 2021, then fell by 2.25% to $2.5 billion in 2022, then fell by 2.26% to $2.5 billion in 2023, then decreased by 23.7% to $1.9 billion in 2024, then crashed by 48.03% to $977.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Depreciation & Amortization (CF) are $977.0 million (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025).